×

Sage Therapeutics takes on major depressive disorder

1:23 PM ET Fri, 8 Dec 2017

CNBC's Meg Tirrell speaks with Sage Therapeutics CEO Jeff Jonas about the company's depression drug, which showed results in a mid-stage drug trial.